Non-Small-Cell Lung Cancer: Real-World Cost Consequence Analysis.
Alessandra BujaGiulia PaselloGiuseppe De LucaAlberto BortolamiManuel ZorziFederico ReaCarlo PinatoAntonella Dal CinDe Polo AnnaMarco SchiavonAndrea ZuinMarco MarchettiGiovanna ScroccaroVincenzo BaldoMassimo RuggeValentina GuarneriPierFranco ContePublished in: JCO oncology practice (2021)
Our study showed a survival improvement for patients with NSCLC as well as an economic burden growth. Physicians should therefore be encouraged to follow new clinical care pathways, while the steadily rising related costs underscore the need for policymakers and health professionals to pursue.